Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes

Diabetes

Jeffrey S. Gonzalez
Havah E. Schneider
Deborah J. Wexler
Christina Psaros Phd
Linda M. Delahanty
Enrico Cagliero Md
Steven A. Safren

October 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Antibodies to Oxidized LDL in Relation to Carotid

Johannes Hulthe
Olov Wiklund
Eva Hurt-camejo
Göran Bondjers
Arterioscler Thromb Vasc Biol
Phospholipase A
Johannes Hulthe
Olov Wiklund
Eva Hurt-camejo
Göran Bondjers

March 2015

The online version of this article, along with updated information and services, is located on th

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased

September 2016

OBJECTIVE—High cholesterol levels in circulating immune complexes (IC), surrogate markers of modifie...

Associated With Higher Risk of Diabetes in

Citable Link
Albert Hollenbeck Phd
Aaron Blair Phd
Arthur Schatzkin

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Immune complexes and the risk of CVD in type 1 diabetes

Lopes-Virella, Maria F.
Bebu, Ionut
Hunt, Kelly J.
Virella, Gabriel
Baker, Nathaniel L.
Braffett, Barbara
Gao, Xiaoyu
Lachin, John M.

September 2019

We investigated whether the composition of modified forms of LDL in circulating immune complexes (LD...

LDL oxidative modifications in well- or moderately controlled type 2 diabetes

Scheffer, P.G.
Henry, R.M.A.
Wever, E.J.M.
van Rooij, G.J.
Bos, G.M.J.
Heine, R.J.
Dekker, J.M.
Diamant, M.
Stehouwer, C.D.A.
Nijpels, G.
Blankenstein, M.A.
Teerlink, T.

January 2004

LDL oxidative modifications in well- or moderately controlled type 2 diabetes.Scheffer PG, Henry RM,...

High-density Lipoprotein Increases the Uptake of Oxidized Low Density Lipoprotein via PPARγ/CD36 Pathway in Inflammatory Adipocytes

Citable Link
Qiaoqing Zhong
Shuiping Zhao
Bilian Yu
Xing Wang
Robina Matyal
Yunping Li

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator1alpha expression. Diabetes 58(7):1499e1508

Citation Estall
Jennifer L
Mario Kahn
Marcus P. Cooper
Ffolliottmartin Fisher
Michele K. Wu
Dina Laznik
Lishu Qu
David E
Gerald I. Shulman
Bruce M. Spiegelman

January 2009

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Management of DiabetesMellitus

Citation Sacks
David B
Mark Arnold
George L. Bakris
David E. Bruns
Andrea Rita Horvath
M. Sue Kirkman
Ake Lernmark
Boyd E. Metzger
David B. Sacks
Mark Arnold
George L. Bakris
David E. Bruns
Andrea Rita Horvath
M. Sue Kirkman
Boyd E. Metzger
David M. Nathan

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes

Gabriel eVirella
Maria F. Lopes-Virella
Maria F. Lopes-Virella

June 2012

The main causes of morbidity and mortality in diabetes are macro and microvascular complications, in...

Atrophy and Cognitive Decline in Type 2 Diabetes

Citable Link
Xingran Cui
Amir Abduljalil
Brad D. Manor
Chung-kang Peng
Vera Novak

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Increased retention of LDL from type 1 diabetic patients in atherosclerosis-prone areas of the murine arterial wall

Hagensen, Mette K
Mortensen, Martin B
Kjolby, Mads
Palmfeldt, Johan
Bentzon, Jacob F
Gregersen, Soeren

July 2019

BACKGROUND AND AIMS: Type 1 diabetes accelerates the development of atherosclerotic cardiovascular d...

Glycation as an atherogenic modification of LDL

Younis, Nahla
Sharma, Reena
Soran, Handrean
Charlton-Menys, Valentine
Elseweidy, Mohamed
Durrington, Paul N.

August 2008

Glycation of LDL occurs chiefly due to the nonenzymatic reaction of glucose and its metabolites with...

Diabetes-Resistant NOR Mice Are More Severely Affected by

Citable Link

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Diabetes

Jeffrey S. Gonzalez
Havah E. Schneider
Deborah J. Wexler
Christina Psaros Phd
Linda M. Delahanty
Enrico Cagliero Md
Steven A. Safren

October 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Antibodies to Oxidized LDL in Relation to Carotid

Johannes Hulthe
Olov Wiklund
Eva Hurt-camejo
Göran Bondjers
Arterioscler Thromb Vasc Biol
Phospholipase A
Johannes Hulthe
Olov Wiklund
Eva Hurt-camejo
Göran Bondjers

March 2015

The online version of this article, along with updated information and services, is located on th

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased

September 2016

OBJECTIVE—High cholesterol levels in circulating immune complexes (IC), surrogate markers of modifie...

Associated With Higher Risk of Diabetes in

Citable Link
Albert Hollenbeck Phd
Aaron Blair Phd
Arthur Schatzkin

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Immune complexes and the risk of CVD in type 1 diabetes

Lopes-Virella, Maria F.
Bebu, Ionut
Hunt, Kelly J.
Virella, Gabriel
Baker, Nathaniel L.
Braffett, Barbara
Gao, Xiaoyu
Lachin, John M.

September 2019

We investigated whether the composition of modified forms of LDL in circulating immune complexes (LD...

LDL oxidative modifications in well- or moderately controlled type 2 diabetes

Scheffer, P.G.
Henry, R.M.A.
Wever, E.J.M.
van Rooij, G.J.
Bos, G.M.J.
Heine, R.J.
Dekker, J.M.
Diamant, M.
Stehouwer, C.D.A.
Nijpels, G.
Blankenstein, M.A.
Teerlink, T.

January 2004

LDL oxidative modifications in well- or moderately controlled type 2 diabetes.Scheffer PG, Henry RM,...

High-density Lipoprotein Increases the Uptake of Oxidized Low Density Lipoprotein via PPARγ/CD36 Pathway in Inflammatory Adipocytes

Citable Link
Qiaoqing Zhong
Shuiping Zhao
Bilian Yu
Xing Wang
Robina Matyal
Yunping Li

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator1alpha expression. Diabetes 58(7):1499e1508

Citation Estall
Jennifer L
Mario Kahn
Marcus P. Cooper
Ffolliottmartin Fisher
Michele K. Wu
Dina Laznik
Lishu Qu
David E
Gerald I. Shulman
Bruce M. Spiegelman

January 2009

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Management of DiabetesMellitus

Citation Sacks
David B
Mark Arnold
George L. Bakris
David E. Bruns
Andrea Rita Horvath
M. Sue Kirkman
Ake Lernmark
Boyd E. Metzger
David B. Sacks
Mark Arnold
George L. Bakris
David E. Bruns
Andrea Rita Horvath
M. Sue Kirkman
Boyd E. Metzger
David M. Nathan

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes

Gabriel eVirella
Maria F. Lopes-Virella
Maria F. Lopes-Virella

June 2012

The main causes of morbidity and mortality in diabetes are macro and microvascular complications, in...

Atrophy and Cognitive Decline in Type 2 Diabetes

Citable Link
Xingran Cui
Amir Abduljalil
Brad D. Manor
Chung-kang Peng
Vera Novak

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Increased retention of LDL from type 1 diabetic patients in atherosclerosis-prone areas of the murine arterial wall

Hagensen, Mette K
Mortensen, Martin B
Kjolby, Mads
Palmfeldt, Johan
Bentzon, Jacob F
Gregersen, Soeren

July 2019

BACKGROUND AND AIMS: Type 1 diabetes accelerates the development of atherosclerotic cardiovascular d...

Glycation as an atherogenic modification of LDL

Younis, Nahla
Sharma, Reena
Soran, Handrean
Charlton-Menys, Valentine
Elseweidy, Mohamed
Durrington, Paul N.

August 2008

Glycation of LDL occurs chiefly due to the nonenzymatic reaction of glucose and its metabolites with...

Diabetes-Resistant NOR Mice Are More Severely Affected by

Citable Link

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Diabetes

Jeffrey S. Gonzalez
Havah E. Schneider
Deborah J. Wexler
Christina Psaros Phd
Linda M. Delahanty
Enrico Cagliero Md
Steven A. Safren

October 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease

January 2016

(Article begins on next page) The Harvard community has made this article openly available. Please s...

Antibodies to Oxidized LDL in Relation to Carotid

Johannes Hulthe
Olov Wiklund
Eva Hurt-camejo
Göran Bondjers
Arterioscler Thromb Vasc Biol
Phospholipase A
Johannes Hulthe
Olov Wiklund
Eva Hurt-camejo
Göran Bondjers

March 2015

The online version of this article, along with updated information and services, is located on th

Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes

Abstract

Extracted data

Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes

Abstract

Extracted data

Related items

Related items